Page last updated: 2024-09-02

ci 988 and flupenthixol

ci 988 has been researched along with flupenthixol in 1 studies

Compound Research Comparison

Studies (ci 988)	Trials (ci 988)	Recent Studies (post-2010) (ci 988)	Studies (flupenthixol)	Trials (flupenthixol)	Recent Studies (post-2010) (flupenthixol)
147	8	14	929	128	138

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Frommelt, L; Goebel-Stengel, M; Hofmann, T; Klapp, BF; Kobelt, P; Lembke, V; Mönnikes, H; Stengel, A; Wiedenmann, B	1

Other Studies

1 other study(ies) available for ci 988 and flupenthixol

Article	Year
The CCKB antagonist CI988 reduces food intake in fasted rats via a dopamine mediated pathway. Peptides, 2013, Volume: 39 Topics: Aminopyridines; Amphibian Proteins; Animals; Appetite Depressants; Dopamine; Eating; Flupenthixol; Food Deprivation; Indoles; Male; Meglumine; Peptide Hormones; Photoperiod; Rats; Rats, Sprague-Dawley; Receptor, Cholecystokinin B; Receptors, Corticotropin-Releasing Hormone; Signal Transduction	2013

Article

Year

The CCKB antagonist CI988 reduces food intake in fasted rats via a dopamine mediated pathway.

Peptides, 2013, Volume: 39

Topics: Aminopyridines; Amphibian Proteins; Animals; Appetite Depressants; Dopamine; Eating; Flupenthixol; Food Deprivation; Indoles; Male; Meglumine; Peptide Hormones; Photoperiod; Rats; Rats, Sprague-Dawley; Receptor, Cholecystokinin B; Receptors, Corticotropin-Releasing Hormone; Signal Transduction

2013